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RESE ARCH ARTICLE

Propofol inhibits prokaryotic voltage-gated
Na+ channels by promoting activation-coupled
inactivation
Elaine Yang1, Daniele Granata2, Roderic G. Eckenhoff3, Vincenzo Carnevale2, and Manuel Covarrubias1

Propofol is widely used in the clinic for the induction and maintenance of general anesthesia. As with most general
anesthetics, however, our understanding of its mechanism of action remains incomplete. Local and general anesthetics
largely inhibit voltage-gated Na+ channels (Navs) by inducing an apparent stabilization of the inactivated state, associated in
some instances with pore block. To determine the biophysical and molecular basis of propofol action in Navs, we investigated
NaChBac and NavMs, two prokaryotic Navs with distinct voltage dependencies and gating kinetics, by whole-cell patch
clamp electrophysiology in the absence and presence of propofol at clinically relevant concentrations (2–10 µM). In both
Navs, propofol induced a hyperpolarizing shift of the pre-pulse inactivation curve without any significant effects on recovery
from inactivation at strongly hyperpolarized voltages, demonstrating that propofol does not stabilize the inactivated
state. Moreover, there was no evidence of fast or slow pore block by propofol in a non-inactivating NaChBac mutant
(T220A). Propofol also induced hyperpolarizing shifts of the conductance-voltage relationships with negligible effects on
the time constants of deactivation at hyperpolarized voltages, indicating that propofol does not stabilize the open state.
Instead, propofol decreases the time constants of macroscopic activation and inactivation. Adopting a kinetic scheme of
Nav gating that assumes preferential closed-state recovery from inactivation, a 1.7-fold acceleration of the rate constant
of activation and a 1.4-fold acceleration of the rate constant of inactivation were sufficient to reproduce experimental
observations with computer simulations. In addition, molecular dynamics simulations and molecular docking suggest that
propofol binding involves interactions with gating machinery in the S4–S5 linker and external pore regions. Our findings
show that propofol is primarily a positive gating modulator of prokaryotic Navs, which ultimately inhibits the channels by
promoting activation-coupled inactivation.

Introduction

General anesthetics are used on millions of patients each year and
yet remain some of the most toxic and poorly understood drugs,
as the exact mechanisms by which they elicit clinical endpoints
and adverse effects are not known. Propofol is one of the most
commonly used intravenous agents for induction of anesthesia
and is often used for maintenance in certain surgical procedures
(James and Glen, 1980; Feng et al., 2017). Studies have shown that
propofol potentiates some eukaryotic and prokaryotic inhibitory
ligand-gated ion channels and inhibits excitatory ones (Hales
and Lambert, 1991; Lin et al., 1992; Belelli et al., 1999; Dilger,
2002; Weng et al., 2010; Zhou et al., 2012). Moreover, high-resolution structural studies and photoaffinity labeling experiments
have revealed the sites of propofol action in several ligand-gated

ion channels, including GABAA receptors and GLIC (Nury et al.,
2011; Chiara et al., 2014; Jayakar et al., 2014; Woll et al., 2018).
The anesthetic effects of propofol are thus likely due in part to
effects on ionotropic receptors. Current models of general anesthetic action, however, suggest that the modulation of multiple
protein targets, including other ion channels, is responsible for
the clinical endpoints of anesthesia as well as off-target effects
(Hemmings et al., 2005; Franks, 2008).
Previous work with isolated rat neurohypophysial nerve terminals demonstrated that propofol and the inhaled anesthetic
isoflurane depress excitatory neurotransmission by inhibiting
presynaptic voltage-gated Na+ channels (Navs; Ouyang et al.,
2003). In the nerve terminals, inhibition results from the anes-
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thetic-induced hyperpolarization of voltage-dependent inactivation, a universal feature of general anesthetics in prokaryotic and
eukaryotic Navs (Rehberg and Duch, 1999; Ouyang et al., 2009;
Barber et al., 2014; Covarrubias et al., 2015; Sand et al., 2017). Intriguingly, pore-blocking local anesthetics, such as lidocaine and
benzocaine, also induce this hyperpolarizing shift (Strichartz,
1973; Hille, 1977; Lee et al., 2012a). According to the modulated
receptor hypothesis, local anesthetics bind in the pore of inactivated Navs with high affinity and stabilize the inactivated state,
which slows recovery from inactivation and, consequently, hyperpolarizes the voltage dependence of inactivation (Hille, 1977).
It is not known, however, whether propofol also inhibits Navs by
this mechanism.
To gain biophysical and structural insight into the modulation of Navs by propofol, we investigated NaChBac, from Bacillus
halodurans (Ren et al., 2001), and NavMs, from Magnetococcus
marinus (McCusker et al., 2012), two prokaryotic Navs with distinct kinetics and voltage-dependent properties. Despite some
differences, prokaryotic Navs exhibit many structural and functional features of their eukaryotic counterparts and have served
as excellent surrogates for investigations into ion channel selectivity and conductance, gating, and pharmacology (Nurani et
al., 2008; Payandeh et al., 2011; McCusker et al., 2012; Zhang et
al., 2012; Ulmschneider et al., 2013; Finol-Urdaneta et al., 2014;
Catterall, 2015; Ahern et al., 2016; Naylor et al., 2016). In contrast
to the single polypeptide eukaryotic channels consisting of four
contiguous, homologous pore-forming domains, prokaryotic
Navs are a tetrameric assembly of identical subunits, which is experimentally advantageous for mutational studies. Furthermore,
although prokaryotic Navs lack the intracellular inactivation domain responsible for the fast hinged lid mechanism of inactivation, they do exhibit slow inactivation (Catterall, 2001; Pavlov et
al., 2005). This has given us the opportunity to ask fundamental
questions about the modulation of slow inactivation by propofol,
which may underlie the universal hyperpolarizing effect of general anesthetics on steady-state inactivation in Navs.
Several published studies have used prokaryotic Navs to investigate mechanisms of local and general anesthetic action. Biophysical studies suggest that local anesthetics block NaChBac and
NavMs and promote entry into the inactivated state (Lee et al.,
2012a), and crystallographic studies have linked these functional
effects to drug binding sites within the pore domain (Bagnéris et
al., 2014). Volatile general anesthetics such as isoflurane and sevoflurane promote activation and inactivation gating in NaChBac
(Ouyang et al., 2007; Barber et al., 2014; Sand et al., 2017), but
open pore block has not been ruled out. Molecular dynamics
(MD) simulations and 19F-NMR studies have proposed novel volatile anesthetic binding sites, including a subset in the pore domain that may overlap with local anesthetic binding sites (Raju et
al., 2013; Barber et al., 2014; Kinde et al., 2016). The binding sites
associated with the mechanism of action of propofol in Navs,
however, have not been explored.
Our results demonstrate that propofol modulates NaChBac
and NavMs in a similar fashion, despite differences in their kinetics and voltage-dependent properties. Results from NavMs
are particularly significant in that its modulation by general anesthetics has not previously been reported and that its full-length
Yang et al.
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crystal structure was recently solved (Sula et al., 2017), allowing
structural interpretation of biophysical results and direct modeling of potential interactions. Here, we show that propofol primarily accelerates voltage-dependent activation and separately
accelerates slow inactivation to a more modest degree. Recovery from inactivation and deactivation are largely unaffected,
and furthermore, there is no evidence of open pore block. The
modulated receptor mechanism of local anesthetics thus fails to
describe the mechanism of action of propofol on these Navs. Instead, propofol inhibits these Navs by promoting activation and,
subsequently, activation-coupled slow inactivation. Consistent
with the functional results, MD simulations of NavMs revealed
two potential propofol binding sites: an extracellular pocket near
the selectivity filter at the intersubunit interface and an intracellular pocket lined by the S4–S5 linker and S6 helix of neighboring subunits. To link functional effects with structural elements
of the ion channels, the companion article by Wang et al. in this
issue uses 19F-NMR to probe putative propfol binding sites in
NaChBac. Altogether, this study elucidates the biophysical and
molecular basis of propofol action on prokaryotic Navs and provides a sound starting point for future investigation of the mechanisms of propofol action on eukaryotic Navs.

Materials and methods

Molecular and cell biology
WT NaChBac cDNA in a modified pTracer-CMV2 expression
vector was a gift from D. Ren (University of Pennsylvania,
Philadelphia, PA), and WT NavMs cDNA in a modified pTracer-CMV2 expression vector was a gift from P. DeCaen (Northwestern University, Evanston, IL) and D. Clapham (Harvard
University, Boston, MA). cDNA was amplified in bacterial culture and purified with the QIAGEN Plasmid Midi kit. To generate NaChBac T220A, a point mutation was introduced into the
WT plasmid using the QuikChange site-directed mutagenesis
method (Agilent).
HEK-293 (NaChBac) or HEK-293T (NavMs) cells were transiently transfected with cDNA using the Lipofectamine 2000
transfection reagent (Invitrogen) and seeded onto 12-mm circular glass coverslips 24 h before patch clamp recording. Standard protocols were followed for growth and maintenance of
cells in culture.
Electrophysiology
Patch pipettes were pulled from borosilicate capillary glass (LA16;
Dagan) with a HEKA PIP6 micropipette puller. Before recording,
patch pipettes were fire polished to a final resistance of 1.5 –2.3
MΩ. Whole-cell patch clamp recording was performed using
an Axopatch 200B amplifier (Molecular Devices) and Digidata
1440A analogue-to-digital converter (Molecular Devices). Series
resistance was compensated at least 85%. Passive leak current
and capacitive transients were subtracted online by standard P/4
protocol (NaChBac) or offline using the passive leak subtraction
feature in pCLAMP (NavMs). All recordings were low-pass Bessel-filtered at 2 kHz and digitized at 15.4 kHz. Clampex 10 (pCLAMP
10; Molecular Devices) was used to control voltage protocols and
for data acquisition.
Journal of General Physiology
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For NaChBac recordings, the extracellular bath solution contained (in mM) 140 NaCl, 4 KCl, 1.5 CaCl2, 1.5 MgCl2, 10 HEPES,
and 5 D-glucose, pH 7.3, adjusted with NaOH; the intracellular
pipette solution contained (in mM) 15 NaCl, 80 CsF, 40 CsCl, 10
EGTA, and 10 HEPES, pH 7.3, adjusted with CsOH. For NavMs
recordings, the extracellular bath solution contained (in mM)
150 NaCl, 1.8 CaCl2, 1 MgCl2, and 10 HEPES, pH 7.4, adjusted with
NaOH; the intracellular pipette solution contained (in mM) 30
NaCl, 110 CsF, 1 KCl, 10 HEPES, and 5 EGTA, pH 7.4, adjusted with
CsOH. Propofol stock solution (400 µM in bath solution) was prepared by diluting 2,6-diisopropylphenol (Sigma-Aldrich) in bath
solution, followed by alternating sonication and vortexing for 4.5
min. The stock solution was then diluted to working concentrations; all dilutions were prepared and used the same day. Cells
were continuously perfused with bath solution at room temperature (22–25°C) during recordings. In all experiments, all control
recordings were collected first, before any anesthetic exposure.
After control recordings, propofol was perfused for ∼3 min before collecting paired anesthetic recordings and continuously
thereafter. To prevent inaccuracies caused by any membrane
lipid retention of anesthetic molecules and cumulative effects,
each experimental cell was only exposed to one concentration of
anesthetic, and washout data were not used.
Voltage protocols
In NaChBac WT and T220A, voltage-dependent activation was
assessed with Na+ currents evoked by 500-ms depolarizing steps
(−100 to +60 mV, ΔV = 10 mV) from a holding potential of −120
mV. Pre-pulse inactivation was assessed with a two-pulse protocol: (1) a 2-s conditioning pulse (−120 mV to −10 mV, ΔV = 10 mV),
followed immediately by (2) a 50-ms test pulse to +10 mV. The
holding potential was −120 mV. A two-pulse protocol was also
used to characterize recovery from inactivation: (1) a 2-s conditioning pulse at −10 mV, followed by (2) a 50-ms test pulse to −10
mV. The pulses were separated by a variable recovery interval (Δt
= 10 ms to 12 s) at −120 mV. The rate of inactivation at −55 mV was
determined with a two-pulse protocol: (1) a conditioning pulse of
variable duration (Δt = 10 ms to 5 s) at −55 mV, followed by (2) a
50-ms test pulse to −10 mV. The holding potential was −140 mV.
Deactivation currents were elicited by 900-ms hyperpolarizing
steps (−120 to −60 mV, ΔV = 10 mV) after a short 15–20 ms activating pulse to −10 mV.
In NavMs, voltage-dependent activation was assessed with
Na+ currents evoked by 200-ms depolarizing steps (−140 to +40
mV, ΔV = 10 mV) from a holding potential of −180 mV. Pre-pulse
inactivation was assessed with a two-pulse protocol: (1) a 1-s
conditioning pulse (−170 mV to −60 mV, ΔV = 10 mV), followed
immediately by (2) a 50-ms test pulse to −30 mV. Recovery from
inactivation was also characterized with a two-pulse protocol: (1)
a 500-ms conditioning pulse at −30 mV, followed by (2) a 50-ms
test pulse to −30 mV. The pulses were separated by a variable recovery interval (Δt = 10 ms to 10 s) at −180 mV.
Data analysis
Clampfit 10 (pCLAMP 10, Molecular Devices), Origin 9.1 (OriginLab), and Excel 2013 (Microsoft) were used to analyze voltage-clamp data. All evaluated parameters are reported as mean
Yang et al.
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± SEM. The paired samples t test was used to assess differences
between paired datasets in the absence and presence of propofol.
P values less than 0.05 are explicitly reported in the figures and
figure legends, and NS indicates P ≥ 0.05.
Peak chord conductance (G) was calculated using G = I / [V −
Vrev], where I is the measured peak current, V is the command
potential, and Vrev is the reversal potential extrapolated from individual current–voltage curves. The voltage dependence of activation (G-V curve) was derived from the best-fit fourth order
Boltzmann function G(V) = [Gmax / (1 + e (Vs – V)/k)]4 and normalized to Gmax, where Gmax is the maximum peak conductance, Vs is
the midpoint of activation for a single subunit, V is the command
potential, and k is the slope factor. The midpoint voltage of activation was calculated using V1/2 = (Vs + 1.67k), and the effective
gating charge (z) was calculated uzing z = 25.5/k. Pre-pulse inactivation parameters were determined from the best-fit first order
Boltzmann function I(V) = Imax / (1 + e (V1/2 – V)/k) and normalized to
Imax, where Imax is the maximum current amplitude and V1/2 is the
midpoint voltage of inactivation. Time constants of activation
and inactivation were derived from the rising and decaying components of the Na+ current, respectively, using the best-fit single
exponential of the form I(t) = (A e −t/τ + C), where A is the amplitude, C is the plateau constant, t is time, and τ is the time constant
of activation or inactivation. Time constants of deactivation were
derived from tail current relaxations using the best-fit double exponential of the form I(t) = (A1 e −t/τ1 + A2 e −t/τ2 + C) as a weighted
mean of τ1 and τ2, where An is the nth component amplitude and
τn is the nth component time constant. Time courses of recovery
from inactivation were determined by plotting fractional recovery from inactivation (Ipeak, pulse 2/Ipeak, pulse 1) against the recovery
interval (Δt). Time constants of recovery were then derived from
the time courses of recovery using the best-fit single exponential
of the form y(t) = [y0 + A (1 – e −t/τ)], where A is the amplitude, t
is the recovery interval, τ is the time constant of recovery from
inactivation, and y0 is the y intercept. Time courses of the onset
inactivation were determined by plotting fractional inactivation
(Ipeak, pulse 2/Io) versus the conditioning pulse duration (Δt), where
Io is the maximum peak current amplitude. The inactivation time
constants were then determined from the time courses of inactivation using the best-fit single exponential of the form y(t) = [y0
+ A e−t/τ], where A is the amplitude, t is the conditioning pulse
interval, τ is the inactivation time constant, and y0 is the y offset.
Kinetic modeling
Kinetic modeling was based on the six-state kinetic model of
NaChBac gating previously proposed by Kuzmenkin et al. (2004),
which has been used by others to model interactions of sevoflurane and isoflurane with NaChBac (Barber et al., 2014; Sand et al.,
2017). This gating scheme was modified to strictly allow closedstate recovery from inactivation, as described in Results and in the
Online supplemental material, to globally simulate all key aspects
of Nav gating examined experimentally. All kinetic simulations
were performed in IonChannelLab (Santiago-Castillo et al., 2010).
The objective of these simulations was to qualitatively account
for all major voltage-dependent and kinetic features of a stereotypical prokaryotic Nav in the absence and presence of propofol.
These features included the voltage dependencies of activation
Journal of General Physiology
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and inactivation and the kinetics of activation, inactivation, deactivation, and recovery from inactivation. To generate modeled
datasets, simulated currents were evoked in IonChannelLab using
the experimental voltage protocols and analyzed in the same manner as experimentally observed currents. Rate constants were adjusted manually and kinetic parameters evaluated in an iterative
process. Model parameters were first adjusted to approximate the
control setting without anesthetic, then appropriately refined to
develop a model of propofol modulation (Table S1).
MD simulations and molecular docking
To discover potential propofol binding sites in Navs, we used an
MD protocol, hereafter referred to as MD “flooding simulations.”
In these flooding simulations, a single ion channel molecule is
exposed to a large number of ligand molecules, a procedure that
we have previously implemented to study the binding of the volatile anesthetics isoflurane and sevoflurane to NaChBac (Raju
et al., 2013; Barber et al., 2014). Highly lipophilic ligands with
large water/octanol partition coefficients like general anesthetics
rapidly segregate into the lipid bilayer, resulting in a vanishingly
small bulk solution concentration. Under these conditions, the
near absence of anesthetic molecules in the aqueous compartment raises computational challenges, as binding events become
extremely rare. This is in contrast to physiological conditions
during the administration of volatile anesthetics, where the
bulk solution concentration remains nearly constant because of
the equilibrium between the aqueous phase in the blood stream
and the gaseous phase in the lung alveoli (Eger et al., 1965). Accordingly, increasing the number of anesthetic molecules in the
simulated system ensures that the concentration in the aqueous
compartment remains within the appropriate range during the
equilibrium phase of sampling. This approach also increases
sampling of binding events between the anesthetic molecule and
the molecular surface of the ion channel. Previous computational
investigations of NaChBac using this method showed that general
anesthetics can diffuse in and out of the pore in part because of
their small size and the presence of fenestrations (Payandeh et
al., 2011; Raju et al., 2013; Barber et al., 2014) and also identified
isoflurane binding sites that were later corroborated by 19F-NMR
saturation transfer difference spectroscopy experiments (Kinde
et al., 2016). Thus, even a submicrosecond MD simulation is likely
sufficient to explore all relevant protein cavities in the ion channel. To this end, we applied this computational method to study
the interactions between propofol and NavMs, for which a fulllength crystal structure is available, specifically focusing on putative isoflurane binding sites previously identified in NaChBac
(Raju et al., 2013; Kinde et al., 2016).
MD flooding simulations were performed on the x-ray crystal structure of NavMs in the open conformation (PDB accession
no. 5HVX; Sula et al., 2017) in a fully hydrated lipid bilayer using
NAMD 2.10 (Phillips et al., 2005). The simulation system contained a total of ∼122,000 atoms, which included a NavMs tetramer, 434 lipid molecules (POPC), 25,310 water molecules, 236
ions (Cl− and Na+), and 145 propofol molecules. The ratio of water
to propofol molecules was 174.5, yielding an initial bulk concentration of 0.32 M. The system was equilibrated through three
consecutive 2-ns stages, in which position restraints on differYang et al.
Mechanisms of propofol modulation in prokaryotic Navs

ent groups were progressively released. The CHARMM36 force
field was used for the phospholipids and CHARMM27 for the protein (Lee et al., 2014). Propofol parameters were obtained from
LeBard et al. (2012). To avoid aggregation of propofol molecules,
indicative of low solubility, a short-range repulsive potential was
included between drug molecule pairs, using the collective module of NAMD 2.12 (Phillips et al., 2005). Periodic boundary conditions were used, and the electrostatic potential was evaluated
using the particle mesh Ewald method. The lengths of all bonds
containing hydrogen were constrained with the SHAKE/RATTLE
algorithm. Each system was maintained at a temperature of
300°K and pressure of 1 atm using the Langevin thermostat and
barostat methods as implemented in NAMD 2.10. The rRESPA
(reversible reference system propagator algorithm) multiple
time step method was used, with a high-frequency time step of 2
fs and a low frequency time step of 4 fs. A trajectory of ∼230 ns
was collected for subsequent analysis.
Based on the simulation results, we defined binding regions
for molecular docking calculations to obtain a set of optimal binding poses and to further analyze channel–propofol interactions.
Docking of propofol was performed on the x-ray crystallographic
structure of NavMs in the open state (PDB accession no. 5HVX;
Sula et al., 2017). The protein structure and parameters were
assigned using the Protein Preparation Wizard (Schrödinger;
Sastry et al., 2013), and protonation states were assigned assuming a pH of 7.0. A minimization step was performed using the
OPLS3 force field (Jorgensen et al., 1996; Harder et al., 2016); a
threshold of 0.30 Å was used on the RMSD of the heavy atoms
to assess convergence. Propofol structures and parameters were
assigned using LigPrep (Schrödinger). For each binding site, a set
of top scoring binding poses was then obtained using Glide-SP
(Schrödinger; Friesner et al., 2006).
Online supplemental material
Fig. S1 provides additional NaChBac WT inactivation gating parameters and also demonstrates representative curve fitting for
inactivation kinetics. Fig. S2 provides additional NaChBac WT
and T220A activation gating parameters. Fig. S3 shows representative curve fitting for NaChBac WT activation and deactivation
kinetics. Fig. S4 examines the effects of propofol on the rate of
NaChBac WT inactivation at −55 mV. Fig. S5 shows representative curve fitting for NavMs inactivation kinetics and provides
additional information regarding activation and inactivation gating parameters. Fig. S6 explores other kinetic schemes to model
NaChBac gating, and Fig. S7 investigates a scenario of propofol
modulation that does not include effects on inactivation. Fig.
S8 is a sequence alignment comparing the S4 to S6 segments of
NaChBac and NavMs. Table S1 contains the kinetic model parameters used in IonChannelLab to describe NaChBac gating and
modulation by propofol.

Results

Modulation of WT NaChBac inactivation properties
In general, anesthetics accelerate macroscopic inactivation in
Navs, which could be a result of either accelerated entry into the
inactivated state or slow open channel block. At 2, 5, and 10 µM,
Journal of General Physiology
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Figure 1. Modulation of NaChBac inactivation gating by propofol. (A) Representative paired current families in the absence (control) and presence of
10 µM propofol. Paired scaled INa currents at 0 mV (top) and the voltage protocol (bottom) are shown to the right. (B) Time constants (τ) of inactivation versus
voltage. Propofol reduced τInactivation at 2, 5, and 10 µM (n = 15–19) at all voltages (9.78E-10 < P < 0.015), with the exception of the 10 µM data point at −40 mV (P
= 0.059). (C) Pre-pulse inactivation voltage protocol. (D) Pre-pulse inactivation curves of control and with propofol at 2, 5, and 10 µM (n = 7–11). Corresponding
paired midpoint voltages (V1/2) of inactivation are shown below. Means are indicated in magenta. Error bars indicate ±SEM.

propofol consistently accelerated the decay of macroscopic WT
NaChBac currents over a wide range of membrane potentials
(Fig. 1, A and B). This current decay was well described by a single
exponential function (Fig. S1, B and C). At voltages greater than
−40 mV, where the time constant of inactivation demonstrated
little to no voltage dependence, propofol exposure decreased the
time constants uniformly (Fig. 1 B). At +20 mV, for instance, the
time constant of inactivation was reduced 24 ± 3.9%, 22 ± 5.5%,
and 33 ± 2.5% at 2, 5, and 10 µM, respectively.
Anesthetics also generally induce parallel hyperpolarizing
shifts of the pre-pulse inactivation curves in Navs (Covarrubias
Yang et al.
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et al., 2015), which points to a relative stabilization of the inactivated state. In WT NaChBac, we observed significant hyperpolarizing shifts of the pre-pulse inactivation curves without any
changes in the corresponding effective gating charge of inactivation (Figs. 1 D and S1 A). At 2, 5, and 10 µM, the changes in the
midpoint voltage (V1/2) of inactivation compared with control
were −9.33 ± 0.67, −7.02 ± 1.29, and −11.51 ± 0.65 mV, respectively
(Table 1). These shifts corresponded to a 25%, 29%, and 32% reduction in channel availability in the presence of 2, 5, and 10 µM
propofol, respectively, at the corresponding baseline midpoint
voltage (Fig. 1 D).
Journal of General Physiology
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Table 1. Effect of propofol on NaChBac and NavMs gating parameters
NaChBac WT

NaChBac T220A

NavMs

2 µM

5 µM

10 µM

5 µM

5 µM

ΔV1/2 of activation (mV)

−12.62 ± 0.93

−9.82 ± 1.82

−14.98 ± 1.17

−14.16 ± 0.93

−12.46 ± 1.55

ΔV1/2 of inactivation (mV)

−9.33 ± 0.67

−7.02 ± 1.29

−11.51 ± 0.65

N/A

−13.54 ± 1.61

Changes in the midpoints (V1/2) of activation and inactivation are evident at all concentrations and in all channels tested, P < 0.001, by paired samples t test.

To test whether these shifts were a result of an actual stabilization of the inactivated state, we examined recovery from inactivation at −120 mV, a strongly hyperpolarized voltage that allows
isolated investigation of the recovery process. At the same concentrations, propofol had no significant effect on the kinetics of
recovery from inactivation (Fig. 2), which were all well described
by a single exponential function. At 10 µM, the time constant of
recovery was 1,075 ± 208 ms, compared with 849 ± 125 ms for
paired controls (P = 0.2433). Overall, these results demonstrate
that modulation of NaChBac inactivation by propofol does not involve stabilization of the inactivated state; they do not, however,
eliminate the possibility of open pore block.
A non-inactivating NaChBac mutant demonstrates no evidence
of pore block by propofol
Slow open channel blockers of voltage-gated ion channels induce time-dependent decay of the current, which reflects the
time course of pore block (Armstrong, 1966, 1971; Shin et al.,
2001; Wang et al., 2004; Barber et al., 2014; Sand et al., 2017).
In NaChBac, however, interpretation of changes in this decay
could be confounded by the presence of intrinsic inactivation.
Thus, to directly determine whether propofol acts as a slow open
channel blocker of NaChBac, we generated NaChBac T220A, a
previously reported mutant that lacks macroscopic inactivation
at baseline (Lee et al., 2012a). Examination of this non-inactivating mutant would allow direct observation of any pore
blocking kinetics in the absence of confounding inactivation.
Contrary to these expectations, however, there was no evidence
of slow pore block, as 5 µM propofol failed to induce any current
decay (Fig. 3 A). Moreover, there was a 16 ± 7.4% increase in the
maximum peak current amplitude (P = 0.00614; Figs. 3 B and
S2 B), demonstrating that propofol does not act as a fast resting
state pore blocker either. These results point to gating modulation as the basis for the acceleration of macroscopic current
decay induced by propofol in WT NaChBac (Fig. 1 A, inset; and
Fig. 1 B) rather than open pore block. Consistent with this conclusion and the hyperpolarizing shift of the pre-pulse inactivation curve, propofol also accelerated entry into the inactivated
state (Figs. 1 and S4).
Modulation of NaChBac activation properties
In Navs, inactivation is inherently coupled to channel activation
(Armstrong and Bezanilla, 1977; Armstrong, 1981, 2006; Aldrich
and Stevens, 1987), and thus, effects on activation alone could
account for changes seen in the voltage dependence and kinetics
of inactivation. To evaluate the modulation of activation gating
by propofol, we compared the conductance–voltage (G-V) relaYang et al.
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tionships of WT and non-inactivating T220A NaChBac in the
absence and presence of propofol. In both channels, propofol
induced parallel hyperpolarizing shifts of the G-V curves at all
concentrations (Fig. 4). In WT NaChBac, the changes in the V1/2
of activation compared with control were −12.62 ± 0.93, −9.82
± 1.82, and −14.16 ± 0.93 mV at 2, 5, and 10 µM propofol, respectively (Fig. 4 A and Table 1). At baseline, NaChBac T220A
demonstrates voltage-dependent activation that is more hyperpolarized compared with WT (Figs. 4 B and S3 B, left), which
results from the elimination of inactivation. Nonetheless, 5 µM
propofol similarly induced a parallel hyperpolarizing shift in
the G-V curve, corresponding to a change in the V1/2 of activation of −14.16 ± 0.93 mV, an effect that is also evident in the
current-voltage (I-V) relationships (Fig. 3 B). This demonstrates
that positive modulation of activation by propofol in NaChBac
occurs in a manner that does not depend on the presence of inactivation and suggests that the propofol-induced acceleration
of inactivation could result largely from promoting voltage-dependent activation and pore opening.
To investigate the kinetic basis of this positive modulation, we
determined the time constants of deactivation from tail current
relaxations and the time constants of activation from the rising
phase of the inward Na+ currents (Figs. 5 and S4). As is typical for
voltage-gated ion channels, deactivation dominates at hyperpolarized voltages and activation dominates at depolarized voltages,
with the measured time constants meeting near the V1/2 of activation. At 2 and 5 µM, propofol failed to induce changes in the time
constants of deactivation in WT NaChBac and required a high
concentration (10 µM) to produce observable slowing (Fig. 5 A,
bottom; and Fig. 5 C). In contrast, all concentrations of propofol reduced the time constants of activation (Fig. 5 A, top; and
Fig. 5 C). Very similar effects were seen in NaChBac T220A (Fig. 5,
B and D). These results demonstrate that the propofol-induced
hyperpolarizing shift of the G-V curve is governed primarily by
the acceleration of activation gating.
Modulation of NavMs activation and inactivation
properties by propofol
Results in NaChBac show that propofol does not act via open
pore block and has favorable effects on both voltage-dependent
activation and inactivation gating. We next asked whether the
effects are conserved in NavMs, a prokaryotic Nav for which a
full-length crystal structure was recently determined (Sula et
al., 2017). Compared with NaChBac, NavMs displays gating kinetics one order of magnitude faster and has a more hyperpolarized voltage dependence (Ulmschneider et al., 2013). NavMs
also exhibits high selectivity for Na+ (Ulmschneider et al., 2013;
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pulse inactivation curves (Fig. 6, D and E; and Fig. S5 C), and no
effect on recovery from inactivation (Fig. 6 F). Thus, modulation
by propofol is conserved in both NaChBac and NavMs, suggesting
that fundamentally similar interactions govern these effects and
indicating that NavMs provides a robust system for future structural investigations into general anesthetic action.

Figure 2. Propofol does not affect recovery from inactivation in NaChBac. (A) Time courses of recovery from inactivation. (B) Paired time constants (τ) of recovery in the absence (control) and presence of 2, 5, and 10 µM
propofol (n = 6–8). Inset shows the voltage protocol. Means are indicated in
magenta. Error bars indicate ±SEM.

Naylor et al., 2016) and contains a common binding site for Nav
antagonists in the central pore (Bagnéris et al., 2014; Buyan et al.,
2018). Despite any functional and structural differences, however, 5 µM propofol modulated NavMs gating parameters in a
manner largely mirroring its effects on NaChBac. These effects
include accelerated Na+ current decay (Fig. 6, A and C; and Fig. S5,
A and B), parallel hyperpolarizing shifts of both the G-V and preYang et al.
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Kinetic modeling of prokaryotic Nav gating requires closedstate recovery from inactivation
We next used computer simulations based on a kinetic model of
NaChBac gating previously proposed by Kuzmenkin et al. (2004)
to develop a model of propofol action on prokaryotic Navs. This
kinetic model of NaChBac gating assumes a sequential six-state
gating scheme, with channels making voltage-dependent transitions between the closed and open states and the open and inactivated states (Fig. S6 A). Importantly, it assumes that channel
inactivation is strictly coupled to pore opening and that inactivated channels must recover from inactivation via the open state.
Although the linear model largely reproduces the major features
of NaChBac gating, it does not adequately model recovery from
inactivation at −120 mV, yielding a time constant of recovery
close to experimental values (∼800 ms) but also a time course
of recovery from inactivation with a considerable y offset (Fig.
S6 C). This y offset indicates significant channel reopening from
the inactivated state and produces simulated current families
that exhibit substantial sustained currents that are not observed
experimentally (Fig. S6 B, top). Slowing the rate constant of recovery from inactivation (β2) by an order of magnitude was able
to minimize the sustained current (Fig. S6 B, middle) but was
unable to reproduce the experimentally observed time course of
recovery from inactivation (Fig. S6 C).
To resolve these discrepancies, we introduced an alternative
pathway of recovery from inactivation that does not allow channel reopening (Fig. 7 A, Control). Instead, inactivated channels
preferentially return to the resting/closed state from the inactivated state. In other words, they must first close (Io → Ic) before
they are able to return to the pre-open closed state (Ic → C).
Recovery coupled to deactivation has previously been proposed
by Kuo and Bean (1994) to describe Nav recovery from inactivation in hippocampal CA1 neurons. The model proposed here
demonstrates inactivation pathway hysteresis, whereby separate pathways are taken to enter and leave the inactivated state.
In response to a depolarizing step, the Navs activate, open, and
enter the inactivated state (C → O → Io), which appears absorbing if the depolarized voltage is held. After hyperpolarization,
the inactivated Navs close and enter the inactivated-closed
state (Io → Ic) before returning to the pre-open closed state
(Ic → C), thereby completing the open-inactivation-recovery
cycle. A similar model of activation-coupled inactivation has
been described for K+ channels exhibiting C-type inactivation
(Tilegenova et al., 2017). The proposed model of Nav gating with
inactivation pathway hysteresis closely described prokaryotic
Nav gating kinetics while simultaneously allowing complete
inactivation and sufficiently fast recovery from inactivation
(Table S1; Fig. S6 B, bottom; and Fig. S6 C). We also found that
measurements of the rate of inactivation in NaChBac land
closely to the trajectory of the inward Na+ current, which reJournal of General Physiology
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Figure 3. Propofol does not act as a pore blocker in a non-inactivating NaChBac mutant. (A) Representative paired current families evoked from NaChBac
T220A in the absence (control) and presence of 5 µM propofol. (B) Normalized current-voltage (I-V) relationships of control and 5 µM propofol from NaChBac
T220A. Currents were normalized to the maximum peak current of the paired control for each cell (n = 11). Inset shows the voltage protocol. (C and D) Representative paired current families (C) and normalized I-V relationships from NaChBac WT (D; n = 15) are shown to provide a side-by-side comparison. Error
bars indicate ±SEM.

flects the time-dependent change in open probability at the
corresponding voltage, thus unambiguously demonstrating
that inactivation in NaChBac is strictly coupled to pore opening
(Fig. S4 B; Fineberg et al., 2012).
Propofol primarily accelerates voltage-dependent activation
to promote inactivation in prokaryotic Navs
Using the model of Nav gating with inactivation pathway hysteresis, we next developed a model of propofol modulation
based on the experimentally observed results. First, we determined whether positive modulation of activation alone could be
sufficient to explain the promotion of inactivation (Fig. S7 A),
a feasible scenario when inactivation is strictly coupled to pore
opening. A 1.7-fold acceleration of the forward activation rate
constant α1 combined with a modest 1.25-fold slowing of the
backward deactivation rate constant β1 was sufficient to qualitatively reproduce propofol-induced hyperpolarizing shifts of
the G-V (ΔV1/2 Activation = −8.68 mV) and pre-pulse inactivation
Yang et al.
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(ΔV1/2 Inactivation = −8.23 mV) curves (Fig. S7, B and C). However,
under these model conditions, macroscopic inactivation was
not accelerated compared to control at strongly depolarized
voltages (Fig. S7 D), whereas propofol uniformly decreased experimentally derived time constants of inactivation over the
full range of membrane potentials studied (Fig. 1 B). Thus, to
globally account for all voltage-dependent and kinetic properties, it was necessary to assume a 1.4-fold acceleration of the
forward inactivation rate constant α2 in addition to the changes
in α1 and β1 above. Model parameters can be found in Table S1.
These assumptions were sufficient to closely account for all aspects of propofol modulation of NaChBac and NavMs inactivation (Fig. 7) and activation (Fig. 8) gating. The kinetic modeling
therefore supports the experimental findings that propofol primarily modulates voltage-dependent activation, with separate
but more modest effects on voltage-dependent inactivation,
and ultimately inhibits prokaryotic Navs by promoting activation-coupled inactivation.
Journal of General Physiology
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Figure 4. Propofol induces a relative stabilization of the open state in both WT and non-inactivating NaChBac. (A) WT (n = 15–19): Normalized peak
G-V relationships in the absence (control) and presence of 2, 5, and 10 µM propofol, with corresponding paired V1/2s of activation shown below. (B) T220A (n =
11): Normalized G-V relationships of control and with 5 µM propofol (left) and corresponding paired V1/2s of activation (right). Means are indicated in magenta.
Voltage protocols are the same as those in Fig. 3. Error bars indicate ±SEM.

Discussion

Despite widespread clinical use, the mechanism of action of the
intravenous general anesthetic propofol is not completely understood. This study provides mechanistic insight into the biophysical and molecular basis of interactions between propofol and
two prokaryotic Navs, NaChBac and NavMs. These prokaryotic
Navs share fundamental properties with eukaryotic Navs and
thus serve as powerful models to investigate the mechanisms of
propofol action on Navs. Here, we show that propofol (a) hyperpolarizes the pre-pulse inactivation curve, (b) accelerates the
rate of macroscopic inactivation, (c) does not affect recovery
from inactivation at a strongly hyperpolarized voltage, (d) hyperpolarizes the G-V curve in both the presence and absence of
channel inactivation, (e) does not induce slow or fast open pore
block, (f) accelerates the rate of macroscopic current activation
with only minor effects on deactivation, and (g) induces nearly
identical effects in both NaChBac and NavMs. Using kinetic modeling, we determined that the net inhibitory effect of propofol on
Yang et al.
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prokaryotic Navs can be explained by significant catalytic action
on voltage-dependent activation gating and, separately, modest
catalytic action on slow voltage-independent inactivation gating. These two distinct effects together ultimately promote activation-coupled inactivation, which, as MD simulations of both
NavMs and NaChBac suggest, might be a result of interactions
with the ion channel’s gating apparatus (Wang et al., 2018).
Propofol is a positive gating modulator of prokaryotic Navs
that promotes activation-coupled inactivation
It has been shown that propofol acts as a positive modulator of
various ion channels (Jayakar et al., 2013, 2014; Li et al., 2016;
Ton et al., 2017), which are presumably responsible for both the
desired endpoints and adverse effects of general anesthesia.
Propofol depresses brain activity in part through the positive
modulation of ionotropic GABAA receptors (Orser et al., 1994;
Belelli et al., 1999; Jurd et al., 2003; Zecharia et al., 2009; Woll
et al., 2015). Pain and irritation caused by the administration of
Journal of General Physiology
https://doi.org/10.1085/jgp.201711924

1307

Figure 5. Propofol preferentially accelerates macroscopic activation in both WT and non-inactivating NaChBac. (A and B) Representative scaled INa
currents at −40 mV (top) and deactivation currents at −120 mV (bottom) evoked from WT (A) and T220A (B), in the absence and presence of 10 or 5 µM propofol, respectively. Inset shows the deactivation voltage protocol used for both WT and T220A. INa currents were evoked using the voltage protocols shown in
Fig. 3 B. (C and D) Time constants (τ) of activation (circles, right side) and deactivation (triangles, left side) versus voltage. Propofol reduced τActivation in WT (n
= 15–19) and T220A (n = 10) at all concentrations and voltages shown compared with control (2.74E-8 < P < 0.035), with the exception of T220A at +40 mV (P
= 0.10). In WT (n = 5–6), 2 and 5 µM propofol did not increase τDeactivation, except for 2 µM at −60 mV (P = 3.40E-4); 10 µM increased τDeactivation at all voltages
shown (5.47E-4 < P < 0.015). In T220A (n = 6), 5 µM propofol increased τDeactivation (4.30E-4 < P < 0.035), with the exception of −110 and −70 mV (P = 0.10 and
0.093, respectively). Error bars indicate ±SEM. In most cases, error bars are smaller than symbols.

propofol are likely mediated by activation of TRPA1 channels via
a binding pocket formed by residues of the S5, S6, and first pore
helix (Ton et al., 2017), and recent photoaffinity labeling studies point to sites in the S6 helix that may also contribute to the
ability of propofol to activate TRPA1 channels (Woll et al., 2017b).
Moreover, as in TRPA1 channels, sevoflurane and propofol also
Yang et al.
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positively modulate voltage-gated K+ channels (Woll et al., 2017a;
Barber et al., 2012; Liang et al., 2015; Bu et al., 2018).
In our investigations, we discovered that propofol also sensitizes prokaryotic Navs to changes in membrane potential, an
effect that is evident in both the presence and absence of inactivation (Fig. 4). Ultimately, however, propofol inhibits these
Journal of General Physiology
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Figure 6. Modulation of gating by propofol is conserved in NavMs. (A) Representative paired current families evoked from NavMs in the absence (control)
and presence of 5 µM propofol. Inset shows representative paired scaled INa currents at 0 mV. (B) Voltage protocols for voltage-dependent activation (top) and
pre-pulse inactivation (bottom). (C) Time constants (τ) of inactivation versus voltage (n = 20). 5 µM propofol reduced τInactivation at all voltages shown (3.66E-9 <
P < 0.002). (D and E) Normalized peak G-V relationships (D; n = 20) and normalized pre-pulse inactivation curves (E; n = 12) of control and with 5 µM propofol.
Corresponding paired V1/2s of activation and inactivation are shown below. Means are indicated in magenta. (F) Time course of recovery from inactivation in
the absence and presence of 5 µM propofol (left). Corresponding paired time constants (τ) of recovery from inactivation (top), τControl = 1170 ± 109 ms, τ5 µM =
1436 ± 136 ms (n = 8), and the voltage protocol (bottom) are shown to the right. Error bars indicate ±SEM.

Navs (Fig. 1 D) because inactivation is strictly coupled to activation and pore opening. In the presence of open-state inactiYang et al.
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vation, therefore, entry into the inactivated state is governed
by the voltage-dependent open probability (Fineberg et al.,
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Figure 7. Kinetic modeling of NaChBac inactivation properties. (A) Proposed kinetic scheme in the absence (control) and presence of propofol. Model
parameters are given in Table S1. (B–E) IonChannelLab simulation results of the proposed kinetic schemes. Simulated current families in the absence and
presence of propofol (B). Inset shows scaled currents at +20 mV. Time constants (τ) of inactivation versus voltage of control and with propofol (C). Pre-pulse
inactivation curves (D) and recovery from inactivation time courses (E) in the absence and presence of propofol.

2012). Consistent with this premise, kinetic modeling demonstrated that the primary effect of propofol is to promote activation by accelerating the forward voltage-dependent activation
rate constant (Figs. 7, 8, and S7). This effect alone accounts for
the propofol-induced hyperpolarizing shifts of the G-V and
pre-pulse inactivation curves. Promotion of activation alone
does not, however, account for the uniform acceleration of the
time constants of inactivation (Figs. 1 B and S6 D), strongly
Yang et al.
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arguing in favor of a multimodal effect. Nonetheless, it is the
hyperpolarized pre-pulse inactivation curve that ultimately
dictates inhibition of the inward Na+ current by reducing channel availability.
Shared features between propofol and local anesthetics
Previous studies have suggested that propofol might act as a
pore blocker that stabilizes the inactivated state of Navs, much
Journal of General Physiology
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vation is slowed. Although this pattern of changes might at first
glance resemble local anesthetic-induced stabilization of the inactivated state, our data provide a viable alternative explanation.
At strongly hyperpolarized voltages, propofol does not slow
recovery from inactivation and negligibly slows deactivation in
NaChBac. Propofol therefore does not stabilize the inactivated or
open states. Moreover, in the absence of channel inactivation,
neither instantaneous peak current amplitude reduction nor
blocking kinetics was observed, which is inconsistent with a
mechanism involving fast resting state or slow open pore block,
respectively (Lee et al., 2012a; Goldschen-Ohm and Chanda,
2014). Hence, propofol does not act on prokaryotic Navs via
classical local anesthetic mechanisms, namely the guarded and
modulated receptor hypotheses (Strichartz, 1973; Hille, 1977;
Goldschen-Ohm and Chanda, 2014). Nonetheless, propofol, the
local anesthetics lidocaine and benzocaine, and the lidocaine
derivative ranolazine all accelerate current decay and induce
hyperpolarizing shifts of the G-V and pre-pulse inactivation
curves in WT NaChBac (Figs. 1 and 4; Lee et al., 2012a,b). Resembling the mechanisms of propofol action proposed here, Lee et
al. (2012b) suggested that local anesthetics may promote entry
into the inactivated state. Like propofol, lidocaine also does not
affect recovery from inactivation in NaChBac. Notably, however,
propofol and lidocaine differ in that lidocaine induces robust
fast resting state block of the non-inactivating T220A NaChBac
mutant (Lee et al., 2012a) whereas propofol does not (Figs. 3 A
and S3 B). The dissociation of pore blocking action from effects
on voltage-dependent gating is consistent with a multisite and
multimodal hypothesis of anesthetic action. Although propofol
and local anesthetics appear to diverge with regard to pore blocking mechanisms, they may share overlapping allosteric sites near
and in the pore that are associated with effects on gating.

Figure 8. Kinetic modeling of NaChBac activation properties. Model
parameters are the same as in Fig. 7 and are given in Table S1. (A) Peak G-V
relationships in the absence (control) and presence of propofol. (B and C) Simulated, scaled activation currents at −40 mV (B) and deactivation tail currents
at −120 mV (C) of control and with propofol. (D) Time constants of activation
(circles, right side) and deactivation (triangles, left side) versus voltage, in the
absence and presence of propofol.

like local anesthetics (Haeseler et al., 2001; Ouyang et al., 2003;
Stoetzer et al., 2016). However, the reported effects, namely hyperpolarization of the steady-state inactivation curve, reduction
of peak current amplitude, and slowed recovery from inactivation, could all be attributed to more favorable voltage-dependent
activation. This possibility arises from the inherent coupling of
inactivation to voltage-dependent activation, a shared property
of many voltage-gated ion channels. As a consequence, if voltage-dependent activation is hyperpolarized, steady-state inactivation is necessarily hyperpolarized. Thus, within the range of
voltages over which the Nav undergoes steady-state inactivation,
the peak current amplitude is reduced, and recovery from inactiYang et al.
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Shared features between propofol and halogenated
volatile anesthetics
Despite significant differences in chemical structure, the effects
of halogenated volatile anesthetics on NaChBac share many
features with those of propofol and local anesthetics. Ouyang
et al. (2007) first investigated the modulation of NaChBac by
isoflurane and proposed a mechanism of inhibition resembling
that of local anesthetics. Their results appeared consistent with
state-dependent interactions: stabilization of the inactivated
state and open pore block (see above). We previously reported
that sevoflurane also inhibits NaChBac via a mechanism that
combines favorable voltage-dependent activation and inactivation gating with open pore block (Barber et al., 2014). Interestingly, sevoflurane modestly destabilizes the inactivated state
by accelerating recovery from inactivation. More recently, Sand
et al. (2017) revisited the modulation of NaChBac by isoflurane,
using kinetic modeling to propose a mechanism of inhibition by
isoflurane that involves increased forward activation and inactivation rate constants. Our results with propofol led to a similar
conclusion in NaChBac and NavMs, which is further supported
by semiquantitative global kinetic simulations based on an extended state model that includes inactivation pathway hysteresis (Figs. 7 A and S6). Our experiments additionally exclude the
presence of fast or slow open pore block and demonstrate that
Journal of General Physiology
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propofol has negligible effects on recovery from inactivation and
deactivation kinetics.
Collectively, the similarities between the actions of local and
general anesthetics on prokaryotic Navs suggest that these ion
channels feature multiple structural pathways and binding
pockets that allow promiscuous but functionally important interactions with a group of diverse chemical compounds that generally share significant hydrophobic character. It is particularly
interesting that anesthetics also often have sensitizing effects on
gating through catalytic action or stabilization of activated/open
states in other related tetrameric ion channels, including K+ and
TRPA channels (Woll et al., 2017a, 2017b; Arcisio-Miranda et al.,
2010; Barber et al., 2012; Liang et al., 2015; Ton et al., 2017). This
observation points to the possibility of shared and/or related
binding sites in other ion channels as well.
Potential propofol binding sites and modulatory
mechanisms in NavMs
Definitively linking functional observations to a discrete set of
well-defined binding sites would require extensive investigation
and validation that are beyond the scope of the present study.
However, some qualitative conclusions can be drawn based on
available information, specifically regarding the binding of isoflurane to NaChBac (Raju et al., 2013). Given the many shared
features of NaChBac’s functional response to both isoflurane and
propofol (Sand et al., 2017) and the strikingly similar responses
of NaChBac and NavMs to propofol, these general anesthetics
could share binding sites in prokaryotic Navs. Although largely
speculative, this hypothesis is consistent with many independent observations of distinct general anesthetics across many
ion channels of the 6TM family, as discussed previously.
To this end, we performed MD flooding simulations on
NavMs (see Materials and methods) and assessed the locations
of two putative isoflurane binding sites previously identified in
NaChBac (Raju et al., 2013) for potential propofol binding: an extracellular pocket near the selectivity filter at the intersubunit
interface and an intracellular pocket lined by the S4–S5 linker
and S6 helix of neighboring subunits (Fig. 9 A). Monitoring the
distances between propofol molecules and the side chains lining
these binding sites during the simulation showed that there is
steric complementarity between the propofol molecule and both
binding sites and that binding at each of these locations occurs
within a few tens of nanoseconds (Fig. 9 F). Although this does
not allow us to draw conclusions about occupancy of these sites
under physiological conditions, it shows that binding is possible.
We then performed molecular docking to conduct a more detailed
analysis of the propofol-NavMs interactions at these locations
and identified the side chains in NavMs that are most likely to be
in contact with propofol (Fig. 9, C and E).
At the S4–S5 linker, the propofol molecule fits snugly in a
pocket that is almost perfectly complementary in shape to the
anesthetic molecule (Fig. 9 D). Binding in this pocket seems to be
dominated by nonpolar interactions; the side chains lining the
binding pocket are all hydrophobic in character except for T225.
The propyl and phenyl moieties of propofol establish extensive
interactions with the side chains of V131, V134, N212, and M222
(Fig. 9 E), and in several binding poses, the propofol hydroxyl
Yang et al.
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group is positioned to form a hydrogen bond with the main
chain carbonyl of G130. As the S4–S5 linker is critical for electromechanical coupling and channel gating (Long et al., 2005;
Payandeh et al., 2011), identification of a potential binding site
at the S4–S5 linker is consistent with experimental findings that
propofol acts as a gating modulator of prokaryotic Navs. Propofol
binding on the extracellular side of the pore domain occurred
near the selectivity filter at the interface between adjacent subunits (Fig. 9 B). Here, the propofol molecule established extensive
contacts with R186 and N190 as well as K166 of the adjacent subunit (Fig. 9 C). Propofol might also interact with the outer pore
region to modulate the equilibrium between conductive and
non-conductive conformations of the selectivity filter, which
has been implicated in slow inactivation in both eukaryotic Navs
and in NaChBac (Xiong et al., 2003; Pavlov et al., 2005). Identification of these two potential binding sites lends additional
support to a multisite and multimodal hypothesis of propofol action. In the companion article, Wang et al. (2018) characterized
propofol binding at the S4–S5 linker and at a number of other
candidate binding sites using 19F-NMR. Further investigation will
be required to validate the functional relevance of these sites to
propofol action in Navs.
Although it is not possible to definitively link the binding
pocket formed by the S4–S5 linker and S6 segment to the modulation of activation and inactivation gating based on the results
presented here, it is very likely that interactions at this location
are involved, given that these regions are highly conserved in
both NaChBac and NavMs (Fig. S8) and given their shared functional modulation by propofol. This hypothesis is also strongly
supported by previous work investigating the action of volatile
general anesthetics on structurally related ion channels, such as
NaChBac, Kv, and TRP channels (Woll et al., 2017a, 2017b; Barber
et al., 2012, 2014; Zhang et al., 2013; Liang et al., 2015; Kinde et al.,
2016; Ton et al., 2017; Bu et al., 2018). Toward linking our findings
to mechanisms of general anesthetic action in eukaryotic Navs,
this binding pocket near the S4–S5 linker is especially intriguing
in light of the recent cryo-EM structure of Nav1.4 from electric
eel Electrophorus electricus (EeNav1.4) in complex with the β1
subunit (Yan et al., 2017). In the structure, the III-IV cytoplasmic
linker containing the LFM fast inactivation motif is found wedged
into the corner enclosed by the S4–S5 linkers and S6 of domains
III and IV, precisely the location of the putative propofol binding
pocket in NavMs. If the III-IV cytoplasmic linker mediates fast
inactivation through an allosteric mechanism that induces pore
closure, propofol may mimic the inactivation gate when it binds
to this pocket, thereby promoting entry into the inactivated state.
Limitations of the model system and kinetic modeling
It is uncertain whether the mechanism of propofol action on
NaChBac and NavMs proposed here can be completely extrapolated to eukaryotic Navs. Several experimental observations,
however, are consistent with fundamental aspects of anesthetic
mechanisms: (1) local and general anesthetics universally hyperpolarize the voltage dependence of inactivation gating in
Navs (Hille, 1977; Bean et al., 1983; Ouyang et al., 2003, 2007,
2009; OuYang and Hemmings, 2007; Lee et al., 2012a; Barber
et al., 2014; Sand et al., 2017), (2) local anesthetics are able to
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Figure 9. MD simulations and molecular docking in NavMs. (A) Side view of potential propofol binding sites in NavMs identified by MD simulations.
Alternating subunits are shown in dark/light blue. (B and D) Zoomed-in surface views of the extracellular (B) and S4–S5 linker binding sites (D). (C and E)
The top six propofol binding poses at the extracellular binding site (C) and top 10 propofol binding poses at the S4–S5 linker binding site (E), from molecular
docking simulations. (F) Time courses of the minimum distance between the bound propofol molecule and the residues lining the two binding sites, from MD
simulations. For both sites, propofol binding occurred in three of the four subunits, denoted as Linker 1–3 and Extracellular 1–3; distances are not reported for
the unoccupied subunit. Residues lining the S4–S5 linker site (left) consisted of V134, N212, and A221, and those lining the extracellular site (right) consisted
of R186, M189, and K166.

modulate voltage sensor conformations of eukaryotic Navs
(Sheets and Hanck, 2003, 2007; Muroi and Chanda, 2009), and
(3) Na+ channel blockers inhibit NavMs and hNav1.1 with comparable potencies and at similar binding sites (Bagnéris et al.,
2014). It is conceivable that these similarities are determined
by shared fundamental structural features that underlie slow
inactivation in the pore domain as discussed above. Despite
these observations, major structural features only found in eukaryotic Navs, such as their pseudotetrameric architecture and
the III-IV cytoplasmic linker responsible for fast inactivation
Yang et al.
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(Vassilev et al., 1988; West et al., 1992; Catterall, 2012), could
alter the ways in which anesthetics antagonize Nav function.
These differences could explain why anesthetics do not stabilize the inactivated state of prokaryotic Navs (Fig. 2; Lee et al.,
2012a,b; Barber et al., 2014; Sand et al., 2017) and why general
anesthetics do not inhibit prokaryotic Navs by fast or slow open
channel block (Fig. 3). Propofol might inhibit eukaryotic Navs
through a combination of mechanisms that includes both the
modulation of activation gating and slow inactivation that is
conserved in prokaryotic Navs and local anesthetic-like modJournal of General Physiology
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ulation of fast inactivation gating with open pore block that is
exclusive to eukaryotic Navs.
Ideally, quantitative global kinetic modeling examining
multiple aspects of gating over a wide range of voltages would
provide the most stringent test for possible mechanisms
(Dougherty et al., 2008; Kaulin et al., 2008). This was unfortunately not experimentally feasible in this study because of
limitations in patch stability, which prevented application of
all voltage protocols to the same cell in the absence and presence of propofol. Nonetheless, we were able to produce robust
datasets suitable for semiquantitative kinetic modeling, which
served as a framework to formulate a plausible mechanism of
action. These datasets yielded comprehensive experimental
information on the various aspects of voltage-dependent gating (activation, deactivation, inactivation, and recovery from
inactivation) over a wide range of voltages (−170 to +60 mV).
Moreover, we performed these experiments at three relevant
concentrations of propofol and repeated a critical subset of
these experiments in both NaChBac and NavMs. Notably, the
observed effects demonstrated little concentration dependence,
which indicates that the concentrations of propofol tested may
have been saturating. This is consistent with in vivo observations in tadpoles (Hall et al., 2010). We cannot, however, dismiss
the possibility that cell-to-cell variability obscured concentration dependence, but in any case, the consistency of the results
strengthens the conclusions.
Conclusion
Mounting evidence points to voltage-gated Na+ channels as important general anesthetic targets (Herold and Hemmings, 2012),
but understanding the molecular mechanisms of this modulation
is the first step toward identifying relevant anesthetic binding
regions in Navs. We have found that propofol inhibits NaChBac
and NavMs by promoting activation-coupled inactivation, which
may involve multiple binding sites within the channel. Further
investigation with mutational analysis will be required to assess
the contributions of individual putative binding sites to the effects of propofol on these Navs. Moving forward, recent advances
in photoaffinity labeling techniques and the availability of the
full-length crystal structure for NavMs will permit in-depth
structural investigations to help validate the significance of these
sites in the mechanism of propofol action.
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